Screener
CG Oncology CGON Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 33,528 | 24,207 |
| Total current liabilities | 47,240 | 30,836 |
| Long-term debt | 3,000 | 3,000 |
| Operating lease liabilities, net of current portion | 4,834 | 3,106 |
| Deferred tax liability | 307 | 307 |
| Other liabilities | 1,156 | 1,741 |
| Total liabilities | 56,537 | 38,990 |
| Commitments and contingencies (Note 7) |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's operating lease liabilities?
- CG Oncology (CGON) reported operating lease liabilities of $4.83M in Q2 2026.
- How has CG Oncology's operating lease liabilities changed year-over-year?
- CG Oncology's operating lease liabilities increased by 584.7% year-over-year, from $706K to $4.83M.
- What is the long-term trend for CG Oncology's operating lease liabilities?
- Over 2 years (2023 to 2025), CG Oncology's operating lease liabilities has grown at a 256.8% compound annual growth rate (CAGR), from $244K to $3.11M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about CG Oncology's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude